4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-092658
Chief Financial Officer sold 600 shares at an average $13.02 ($7,814)
- Chief Financial Officer acquired 300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-16 | Exercise or conversion : show line 1 in the form | +100 | $2.10 | $210 | 20,641 | D |
| 2022-08-16 | Sale : show line 2 in the form | −200 | $13.00 | $2,600 | 20,441 | D |
| 2022-08-17 | Exercise or conversion : show line 3 in the form | +100 | $2.10 | $210 | 20,541 | D |
| 2022-08-17 | Sale : show line 4 in the form | −200 | $13.07 | $2,614 | 20,341 | D |
| 2022-08-18 | Exercise or conversion : show line 5 in the form | +100 | $2.10 | $210 | 20,441 | D |
| 2022-08-18 | Sale : show line 6 in the form | −200 | $13.00 | $2,600 | 20,221 | D |
| Open-market sales · 600 sh · avg $13.02 · $7,814 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-16 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −100 | 116,096 | D |
| 2022-08-17 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −100 | 115,996 | D |
| 2022-08-18 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −100 | 115,896 | D |
Loading xslF345X03/tm2224086-1_4seq1.xml…